A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and effectiveness of providing
2-methoxyestradiol to patients with plateau phase or relapsed multiple myeloma. Information
regarding trough 2ME2 levels will also be collected.